13 days ago • Posted by Jasper Lawler

Vaccitech, the biotech behind the AstraZeneca vaccine plans New York IPO

Vaccitech just landed a blow on UK Prime Minister Boris Johnson's vision of the UK as a biotech startup hub around Oxford and Cambridge. The firm is eyeing a listing in New York.

Vaccitech is taking advantage of investor appetite for scientific innovation highlighted by the pandemic, with 2020 a booming year for biotech IPOs. Shares in vaccine maker Moderna have soared almost 300 per cent and shares in BioNTech, which partnered with Pfizer to make a Covid-19 vaccine, have climbed more than 120 per cent in the past year.

via @FT The Financial Times

Vaccitech, the biotech behind the AstraZeneca vaccine plans New York IPO
bg_nwsletter